Cargando…

A Cell-Based Screen Identifies HDAC Inhibitors as Activators of RIG-I Signaling

Enhancing the immune microenvironment in cancer by targeting the nucleic acid sensors is becoming a potent therapeutic strategy. Among the nucleic acid sensors, activation of the RNA sensor Retinoic Acid-inducible Gene (RIG-I) using small hairpin RNAs has been shown to elicit powerful innate and ada...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fraile-Bethencourt, Eugenia, Foss, Marie H., Nelson, Dylan, Malhotra, Sanjay V., Anand, Sudarshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882870/ https://www.ncbi.nlm.nih.gov/pubmed/35237663 http://dx.doi.org/10.3389/fmolb.2022.837610

Ejemplares similares

Comprehensive Analysis of HDAC Family Identifies HDAC1 as a Prognostic and Immune Infiltration Indicator and HDAC1-Related Signature for Prognosis in Glioma
por: Fan, Yuxiang, et al.
Publicado: (2021)

HDAC4 in cancer: A multitasking platform to drive not only epigenetic modifications
por: Cuttini, Emma, et al.
Publicado: (2023)

Validation of Deep Learning-Based DFCNN in Extremely Large-Scale Virtual Screening and Application in Trypsin I Protease Inhibitor Discovery
por: Zhang, Haiping, et al.
Publicado: (2022)

A Staphylococcus aureus clpX Mutant Used as a Unique Screening Tool to Identify Cell Wall Synthesis Inhibitors that Reverse β-Lactam Resistance in MRSA
por: Bæk, Kristoffer T., et al.
Publicado: (2021)

Development of machine learning models for the screening of potential HSP90 inhibitors
por: Khan, Mohd Imran, et al.
Publicado: (2022)

Selective Inhibition of HDAC1 by Macrocyclic Polypeptide for the Treatment of Glioblastoma: A Binding Mechanistic Analysis Based on Molecular Dynamics
por: Zhang, Yang, et al.
Publicado: (2020)

Insights into the function of HDAC3 and NCoR1/NCoR2 co-repressor complex in metabolic diseases
por: Paluvai, Harikrishnareddy, et al.
Publicado: (2023)

Thymidine phosphorylase facilitates retinoic acid inducible gene-I induced endothelial dysfunction
por: Baris, Adrian, et al.
Publicado: (2023)

Ligand-based pharmacophore modeling and QSAR approach to identify potential dengue protease inhibitors
por: Poola, Anushka A., et al.
Publicado: (2023)

A Comprehensive 2D-LC/MS Online Platform for Screening of Acetylcholinesterase Inhibitors
por: Seidl, Claudia, et al.
Publicado: (2022)

In Silico Infection Analysis (iSFA) Identified Coronavirus Infection and Potential Transmission Risk in Mammals
por: Zou, Yanyan, et al.
Publicado: (2022)

An Integrated Computational and Experimental Approach to Identifying Inhibitors for SARS-CoV-2 3CL Protease
por: Zhai, Tianhua, et al.
Publicado: (2021)

Intein Inhibitors as Novel Antimicrobials: Protein Splicing in Human Pathogens, Screening Methods, and Off-Target Considerations
por: Wall, Diana A., et al.
Publicado: (2021)

Phenotype-based drug screening: An in vivo strategy to classify and identify the chemical compounds modulating zebrafish M-cell regeneration
por: Kumari, Ankita, et al.
Publicado: (2022)

Discovery of Potential Flavonoid Inhibitors Against COVID-19 3CL Proteinase Based on Virtual Screening Strategy
por: Xu, Zhongren, et al.
Publicado: (2020)

Homology modeling, virtual screening, molecular docking, and dynamics studies for discovering Staphylococcus epidermidis FtsZ inhibitors
por: Vemula, Divya, et al.
Publicado: (2023)

Nucleic Acid Sensing in the Tumor Vasculature
por: Baris, Adrian M., et al.
Publicado: (2021)

Corrigendum: Phenotype-based drug screening: An in vivo strategy to classify and identify the chemical compounds modulating zebrafish M-cell regeneration
por: Kumari, Ankita, et al.
Publicado: (2023)

Structural and functional characterization of Cas2 of CRISPR-Cas subtype I-C lacking the CRISPR component
por: Anand, Vineet, et al.
Publicado: (2022)

A synthetic lethal screen for Snail-induced enzalutamide resistance identifies JAK/STAT signaling as a therapeutic vulnerability in prostate cancer
por: Ware, Kathryn E., et al.
Publicado: (2023)

A genome–wide CRISPR activation screen identifies SCREEM a novel SNAI1 super-enhancer demarcated by eRNAs
por: Uthaya Kumar, Dinesh Babu, et al.
Publicado: (2023)

In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19
por: Teli, Divya M., et al.
Publicado: (2021)

Structure-Based Virtual Screening to Identify Novel Potential Compound as an Alternative to Remdesivir to Overcome the RdRp Protein Mutations in SARS-CoV-2
por: Kumar D, Thirumal, et al.
Publicado: (2021)

Identification of Potential Inhibitors of 3CL Protease of SARS-CoV-2 From ZINC Database by Molecular Docking-Based Virtual Screening
por: Abdusalam, Ashraf Ahmed Ali, et al.
Publicado: (2020)

Structure, Function and Protein Engineering of Cereal-Type Inhibitors Acting on Amylolytic Enzymes
por: Møller, Marie Sofie, et al.
Publicado: (2022)

Identification of UBE2I as a Novel Biomarker in ccRCC Based on a Large-Scale CRISPR-Cas9 Screening Database and Immunohistochemistry
por: Li, Feng, et al.
Publicado: (2022)

Identification of novel inhibitors for SARS-CoV-2 as therapeutic options using machine learning-based virtual screening, molecular docking and MD simulation
por: Samad, Abdus, et al.
Publicado: (2023)

Systems-based Analysis of RIG-I-dependent Signaling Identifies KHSRP as an Inhibitor of RIG-I Receptor Activation
por: Soonthornvacharin, Stephen, et al.
Publicado: (2017)

Unleashing Nature’s potential: a computational approach to discovering novel VEGFR-2 inhibitors from African natural compound using virtual screening, ADMET analysis, molecular dynamics, and MMPBSA calculations
por: Baammi, Soukayna, et al.
Publicado: (2023)

Mechanisms and inhibitors of ferroptosis in psoriasis
por: Zhou, Qiao, et al.
Publicado: (2022)

Identifying and Visualizing Macromolecular Flexibility in Structural Biology
por: Palamini, Martina, et al.
Publicado: (2016)

Identifying individuals using proteomics: are we there yet?
por: Fierro-Monti, Ivo, et al.
Publicado: (2022)

Solution Structure of the dATP-Inactivated Class I Ribonucleotide Reductase From Leeuwenhoekiella blandensis by SAXS and Cryo-Electron Microscopy
por: Hasan, Mahmudul, et al.
Publicado: (2021)

Protein pI and Intracellular Localization
por: Tokmakov, Alexander A., et al.
Publicado: (2021)

Harnessing the Activation of RIG-I Like Receptors to Inhibit Glioblastoma Tumorigenesis
por: Bufalieri, Francesca, et al.
Publicado: (2021)

Editorial: Type I Chaperonins: Mechanism and Beyond
por: Breiman, Adina, et al.
Publicado: (2018)

Computational Ways to Enhance Protein Inhibitor Design
por: Jernigan, Robert L., et al.
Publicado: (2021)

Peptide-Based Inhibitors of ADAM and ADAMTS Metalloproteinases
por: Pluda, Stefano, et al.
Publicado: (2021)

Sialidase and Sialyltransferase Inhibitors: Targeting Pathogenicity and Disease
por: Bowles, William H. D., et al.
Publicado: (2021)

Structure and Characterization of a Covalent Inhibitor of Src Kinase
por: Gurbani, Deepak, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3rmik7po3gu011o2dj8r1bg1bc